FDA Clearance Tracker · P000025-S104
MED-EL Cochlear Implant System
Last checked: Nov 20, 2026Latest source record: Jul 19, 2019 (this decision)Source: openFDAMethods & limitations
Decided
Jul 19, 2019
Approved
Time to decision
354 days
Received Jul 30, 2018. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P000025-S104
- Device name
- MED-EL Cochlear Implant System
- Applicant
- Med-El Corp.
- Applicant location
- Innsbruck
- Received
- Jul 30, 2018
- Decided
- Jul 19, 2019
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P000025
Device type
- Device type
- Implant, cochlear (MCM)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
Approval for expanding the cochlear implantation indications to include patients 5 years and above with single sided deafness (SSD) and asymmetric hearing loss (AHL) who have profound sensorineural hearing loss in one ear and normal hearing or mild sensorineural hearing loss in the other ear.
Source documents
Other decisions for Med-El Corp.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- MED-EL CI SystemPMA supplement
P000025-S134 · Decided Nov 26, 2025 · 287 days after receipt · Panel Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.